35
HCW Biologics Inc. raises $1.6M under Reg D
Company raise · Closed · Offering $1.6M · Sold $1.6M · MIRAMAR, FL · filed 2026-08-06
35
HCW Biologics closes $1.5M raise under Reg D exemption 6(b)
Company raise · Closed · MIRAMAR, FL · Form D filed 2026-10-08
HCW Biologics Inc., a Delaware biotech corporation based in Miramar, FL, has closed a $1.5M offering under Regulation D exemption 6(b). The raise closed on September 24, 2026, with one investor participating.
other
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Hing Wong | Executive Officer, Director |
| Rebecca Byam | Executive Officer |
| Peter Rhode | Executive Officer |
| Scott Garrett | Director |
| Rick Greene | Director |
| Lisa Giles | Director |
| Lee Flowers | Executive Officer |
Signed by Rebecca Byam, Chief Financial Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
40
HCW Biologics Inc. raises $4M under Reg D
Company raise · Closed · Offering $4M · Sold $4M · MIRAMAR, FL · filed 2026-06-08
45
HCW Biologics Inc. raises $6.9M under Reg D
Company raise · Closed · Offering $6.9M · Sold $6.9M · MIRAMAR, FL · filed 2024-12-05